I'm LongbridgeAI, I can summarize articles.Hong Kong's health-tech sector is reaching an inflection point. Ping An Health's 2025 profit surged over 360%, while Yidu Tech scales its medical AI, proving tech-driven margin expansion is finally materializing.
The fundamental recalculation of Hong Kong’s consumer and healthcare sectors is actively underway. The overarching narrative has shifted strictly to margins and monetization, with health-tech majors finally translating AI infrastructure spend into bottom-line profitability across the 2025 and 2026 fiscal cycles.
Ping An Healthcare and Technology (1833.HK)
The aggressive pivot toward managed care and enterprise health (B2B) is generating hard returns. Total revenue for 2025 hit RMB 5.46 billion, up 13.7% year-over-year, while net profit spiked 366.1% to RMB 380 million—marking its first full-year operating profit. Notably, AI integration is now a quantifiable margin driver, contributing roughly RMB 80 million in gross profit following the deployment of the DeepSeek model in early 2025.
Yidu Tech (2158.HK)
The AI healthcare data operator is demonstrating structural margin recovery. Mid-FY2026 revenue (ended Sept 2025) climbed 8.7% to RMB 358 million, anchored by a 30.3% jump in its health management segment. With its proprietary YiduCore model now powering 280 clinical agents and a recent strategic acquisition of an online physician platform, the company is rapidly scaling its medical AI footprint following domestic regulatory clearances.
- China Mengniu Dairy (2319.HK) — The dairy heavyweight is stepping up capital management, executing a HKD 6.18 million share buyback in June 2026 to stabilize sentiment amid shifting macro consumer dynamics.